Callali
1 known investors
Calla Lily develops Callavid®, a patented vaginal drug delivery platform technology designed to improve convenience and dosage confidence for women. The platform is in clinical development for fertility, threatened miscarriage, and potential future applications in menopause, cancer, and infectious diseases.